US9303033, A19, Table 33A, Compound 124

ID: ALA3968136

Chembl Id: CHEMBL3968136

PubChem CID: 137304476

Max Phase: Preclinical

Molecular Formula: C21H23N9O2

Molecular Weight: 433.48

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)c1ccccc1CNc1nc(NC2CC2)n2ncc(/C=C3\NC(=O)NC3=O)c2n1

Standard InChI:  InChI=1S/C21H23N9O2/c1-29(2)16-6-4-3-5-12(16)10-22-19-26-17-13(9-15-18(31)27-21(32)25-15)11-23-30(17)20(28-19)24-14-7-8-14/h3-6,9,11,14H,7-8,10H2,1-2H3,(H2,22,24,26,28)(H2,25,27,31,32)/b15-9-

Standard InChI Key:  NZZJCKSQVSIHFI-DHDCSXOGSA-N

Alternative Forms

  1. Parent:

    ALA3968136

    ---

Associated Targets(Human)

CSNK2B Tbio Casein kinase II alpha/beta (1504 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK2B Tbio Casein kinase II beta (977 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 433.48Molecular Weight (Monoisotopic): 433.1975AlogP: 1.56#Rotatable Bonds: 7
Polar Surface Area: 128.58Molecular Species: NEUTRALHBA: 9HBD: 4
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.24CX Basic pKa: 4.22CX LogP: 1.28CX LogD: 0.90
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.33Np Likeness Score: -1.17

References

1.  (2016)  Pyrazolopyrimidines and related heterocycles as CK2 inhibitors, 

Source

Source(1):